Sun Pharma is amongst India's largest and fastest growing pharma companies. India and the US account for almost 80% of our business. In India, we're market leaders in six therapies, such as cardiology and psychiatry, with trusted brands and effective marketing teams. In the US, we're a fast growing generic company, with 250 products approved, and presence across dermatologicals and controlled substances. Our global manufacturing base spans 23 sites across continents. We're one of the largest spenders on generic R&D.
0 comments:
Post a Comment